The Croatian Phase I and II clinical trials for inflammatory bowel disease conducted in the 1990s by pharmaceutical company Pliva claimed safety with no significant toxicity, though complete peer-reviewed data never appeared in scientific literature beyond conference abstracts
How do I buy it? The inquiring patients ranged in age and abilities from young athletes hoping to make faster recoveries to older adults living with muscular dystrophy
when amounts of NAD+ are low in the body, the DDR process is impaired, resulting in increased damage to the cellular DNA
Safety and Metabolism of AOD9604, a Novel Nutraceutical Ingredient for Improved Metabolic Health Journal of Endocrinology & Metabolism, Volume 4, Number 3, June 2014, Pages 64-77
Link per Mail an einen Freund senden Fenster schlieen E-Mail an * Absender * Eigene E-Mail * Betreff * Senden Abbrechen
This means it hasn't undergone the rigorous testing required to ensure its safety and efficacy